Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T22655
|
||||
Former ID |
TTDC00248
|
||||
Target Name |
Mucosal addressin cell adhesion molecule 1
|
||||
Gene Name |
MADCAM1
|
||||
Synonyms |
MAdCAM-1; hMAdCAM-1; MADCAM1
|
||||
Target Type |
Clinical Trial
|
||||
Disease | Ulcerative colitis; Inflammatory bowel disease [ICD9: 555, 556, 556.9; ICD10: K50, K50-K52, K51] | ||||
Function |
Cell adhesion leukocyte receptor expressed by mucosal venules, helps to direct lymphocyte traffic into mucosal tissues including the Peyer patches and the intestinal lamina propria. It can bind both integrin alpha-4/beta-7 and L-selectin, regulating both the passage and retention of leukocytes. Isoform 2, lacking the mucin-like domain, may be specialized in supporting integrin alpha-4/beta-7-dependent adhesion strengthening, independent of L- selectin binding.
|
||||
Target Validation |
T22655
|
||||
UniProt ID | |||||
Sequence |
MDFGLALLLAGLLGLLLGQSLQVKPLQVEPPEPVVAVALGASRQLTCRLACADRGASVQW
RGLDTSLGAVQSDTGRSVLTVRNASLSAAGTRVCVGSCGGRTFQHTVQLLVYAFPDQLTV SPAALVPGDPEVACTAHKVTPVDPNALSFSLLVGGQELEGAQALGPEVQEEEEEPQGDED VLFRVTERWRLPPLGTPVPPALYCQATMRLPGLELSHRQAIPVLHSPTSPEPPDTTSPES PDTTSPESPDTTSQEPPDTTSPEPPDKTSPEPAPQQGSTHTPRSPGSTRTRRPEISQAGP TQGEVIPTGSSKPAGDQLPAALWTSSAVLGLLLLALPTYHLWKRCRHLAEDDTHPPASLR LLPQVSAWAGLRGTGQVGISPS |
||||
Drugs and Mode of Action | |||||
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM) | |||||
TEP | EXP Info | ||||
Pathways | |||||
KEGG Pathway | Cell adhesion molecules (CAMs) | ||||
Intestinal immune network for IgA production | |||||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | a4b7 Integrin signaling | ||||
Beta5 beta6 beta7 and beta8 integrin cell surface interactions | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.